{"DataElement":{"publicId":"7312568","version":"1","preferredName":"Choroid And Ciliary Body Uveal Melanoma Pathologic CPTAC N Category","preferredDefinition":"Extent of the regional lymph node involvement for choroidal and ciliary body melanoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy.","longName":"6586423v1.0:7312564v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6586423","version":"1","preferredName":"Choroid And Ciliary Body Uveal Melanoma Pathologic N Category","preferredDefinition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens._A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"6586235v1.0:2428379v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6586235","version":"1","preferredName":"Choroid And Ciliary Body Uveal Melanoma","preferredDefinition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens.:A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","longName":"C12344:C37912:C12345:C7712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid","conceptCode":"C12344","definition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ciliary Body","conceptCode":"C12345","definition":"Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB15681-4CE4-0958-E053-F662850A2AAD","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7CB13E05-17A5-0950-E053-F662850A9877","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9-6-19 TMT released per MC.; 12/10/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7312564","version":"1","preferredName":"Uveal Melanoma CPTAC N Category","preferredDefinition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B._A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"7312564v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pN0","valueDescription":"N0 Stage Finding","ValueMeaning":{"publicId":"3202490","version":"1","preferredName":"N0 Stage Finding","longName":"3202490","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0CF7-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6BD2666-C62E-32AB-E053-4EBD850A15D8","beginDate":"2020-05-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"ONEDATA","dateModified":"2020-05-28","deletedIndicator":"No"},{"value":"pNX","valueDescription":"NX Stage Finding","ValueMeaning":{"publicId":"3202502","version":"1","preferredName":"NX Stage Finding","longName":"3202502","preferredDefinition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0EAB-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6BD2666-C642-32AB-E053-4EBD850A15D8","beginDate":"2020-05-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"ONEDATA","dateModified":"2020-05-28","deletedIndicator":"No"},{"value":"pN1","valueDescription":"Uveal Melanoma pN1 TNM Finding v8","ValueMeaning":{"publicId":"6586466","version":"1","preferredName":"Uveal Melanoma pN1 TNM Finding v8","longName":"6586466","preferredDefinition":"Uveal melanoma with regional lymph node metastasis or discrete tumor deposits in the orbit. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pN1 TNM Finding v8","conceptCode":"C140653","definition":"Uveal melanoma with regional lymph node metastasis or discrete tumor deposits in the orbit. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB23D8E-4A70-022D-E053-F662850ABCBD","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6BD2666-C657-32AB-E053-4EBD850A15D8","beginDate":"2018-12-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"ONEDATA","dateModified":"2020-05-28","deletedIndicator":"No"},{"value":"pN1a","valueDescription":"Uveal Melanoma pN1a TNM Finding v8","ValueMeaning":{"publicId":"6586464","version":"1","preferredName":"Uveal Melanoma pN1a TNM Finding v8","longName":"6586464","preferredDefinition":"Uveal melanoma with metastasis in one or more regional lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pN1a TNM Finding v8","conceptCode":"C140654","definition":"Uveal melanoma with metastasis in one or more regional lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB23D8E-4A4A-022D-E053-F662850ABCBD","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6BD2666-C66B-32AB-E053-4EBD850A15D8","beginDate":"2018-12-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"ONEDATA","dateModified":"2020-05-28","deletedIndicator":"No"},{"value":"pN1b","valueDescription":"Uveal Melanoma pN1b TNM Finding v8","ValueMeaning":{"publicId":"6586557","version":"1","preferredName":"Uveal Melanoma pN1b TNM Finding v8","longName":"6586557","preferredDefinition":"Uveal melanoma in which no regional lymph nodes are positive, but there are discrete tumor deposits in the orbit that are not contiguous to the eye. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pN1b TNM Finding v8","conceptCode":"C140655","definition":"Uveal melanoma in which no regional lymph nodes are positive, but there are discrete tumor deposits in the orbit that are not contiguous to the eye. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFAC70-B46B-078F-E053-F662850A9B23","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6BD2666-C67F-32AB-E053-4EBD850A15D8","beginDate":"2018-12-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"ONEDATA","dateModified":"2020-05-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7312563","version":"1","preferredName":"Uveal Melanoma Clinical Proteomic Tumor Analysis Consortium N Category Category","preferredDefinition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.:A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C7712:C157175:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Proteomic Tumor Analysis Consortium","conceptCode":"C157175","definition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BD2666-C5FA-32AB-E053-4EBD850A15D8","latestVersionIndicator":"Yes","beginDate":"2020-05-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"ONEDATA","dateModified":"2020-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BD2666-C60B-32AB-E053-4EBD850A15D8","latestVersionIndicator":"Yes","beginDate":"2020-05-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"KNABLEJ","dateModified":"2020-05-28","changeDescription":"5/28/20 jk Re-created post db reload; CPTAC requires N0, and NX in addition to AJCC ed 8 PVs.  Replaced VD 7284008.  9-6-19 TMT released per MC.; 12/11/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779574","version":"1","longName":"UVM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic Regional Lymph Nod","type":"Preferred Question Text","description":"Pathologic Regional Lymph Node Status (pN)","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BD3F30-A0D9-43E3-E053-4EBD850A341C","latestVersionIndicator":"Yes","beginDate":"2020-05-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-05-28","modifiedBy":"KNABLEJ","dateModified":"2020-05-28","changeDescription":"5/28/20 jk Re-created post db reload; CPTAC requires N0, and NX in addition to AJCC ed 8 PVs.  Replaced CDE 7284009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}